Skip to main content

Bon Natural Life Ltd

corporate_fare Company Profile

Bon Natural Life Ltd

BON·NASDAQ·Consumer Defensive·CIK 0001816815

Bon Natural Life Limited researches, develops, manufactures, and sells functional active ingredients derived from natural herb plants. The company operates in the People's Republic of China, Europe, North America, and the Middle East. Its offerings include personal care ingredients, specifically plant-extracted fragrance compounds supplied to perfume and fragrance manufacturers. Additionally, Bon Natural Life Limited provides natural health supplements, which encompass powder drinks and bioactive food ingredient products. These products are utilized as food additives and nutritional supplements. The company distributes its products through direct distributors, serving manufacturer customers across the functional food, personal care, cosmetic, and pharmaceutical industries. Established in 2006, Bon Natural Life Limited is headquartered in Xi'an, the People's Republic of China, and maintains a strategic partnership with Tigerbone Group Limited.

Bon Natural Life Ltd (NASDAQ:BON) is a publicly traded company in the Consumer Defensive sector. Wiseek monitors BON SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Bon Natural Life Forms Strategic Alliance with Tigerbone Group for New Health Initiatives
  • Bon Natural Life Appoints Controller's Wife as CTO for $1,000/Month Salary
  • Bon Natural Life Forms Strategic Partnership for AI-Driven Biomanufacturing Lab

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$18.67M
Net Income
-$1.99M
Diluted EPS
-$0.72
Op. Cash Flow
$141.12K
Free Cash Flow
$134.29K
Gross Profit
$3.88M
Operating Income
-$1.62M
Cash & Equivalents
$3.77M
Total Debt
$1.92M
Debt / Equity
0.03×
Net Margin
-10.7%
Shares Outstanding
2.76M sh
Source: 20-F · filed 2026-01-22 · accession 0001493152-26-003270

Insider Transactions

BON files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →
$1.41 -0.07% today
52-week range · as of 2026-03-19 $1.14 – $15.75
Market cap
$10.97M
Volume
40.5K (1.8× avg)
3-mo avg 22.9K
Live data · 2026-06-14 05:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BON - Latest Insights

BON
Mar 31, 2026, 9:28 AM EDT
Source: Reuters
Importance Score:
7
Bon Natural Life Forms Strategic Alliance with Tigerbone Group for New Health Initiatives
Price at Filing: $1.29
Real-time Price: $1.41 info
Change: +$0.120 (+9%) info
Market Cap: $10.974M info
Sentiment: Positive
View Wiseek Article
BON
Mar 19, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
8
Bon Natural Life Appoints Controller's Wife as CTO for $1,000/Month Salary
Price at Filing: $1.47
Real-time Price: $1.41 info
Change: -$0.060 (-4%) info
Market Cap: $10.974M info
Sentiment: Negative
View Wiseek Article
BON
Feb 17, 2026, 9:00 AM EST
Filing Type: 6-K
Importance Score:
7
Bon Natural Life Forms Strategic Partnership for AI-Driven Biomanufacturing Lab
Price at Filing: $1.64
Real-time Price: $1.41 info
Change: -$0.230 (-14%) info
Market Cap: $10.974M info
Sentiment: Positive
View Wiseek Article